Evidence map›Paper›PMID 38668034›Full record

Observational studyCurrent oncology (Toronto, Ont.)2024

Prognostic Factors Associated with Tumor Recurrence and Overall Survival in Soft Tissue Sarcomas of the Extremities in a Colombian Reference Cancer Center.

Sandra E Díaz Casas, Juanita Martínez Villacrés, Carlos Lehmann Mosquera, Mauricio García Mora, Iván Mariño Lozano, Javier Ángel Aristizábal, Raúl Suarez Rodríguez, Carlos Alfonso Duarte Torres, Ricardo Sánchez Pedraza

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Current oncology (Toronto, Ont.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Sandra E Díaz CasasFunctional Unit for Breast and Soft Tissue Tumors, Instituto Nacional de Cancerología, Bogotá 111511, Colombia.
Juanita Martínez VillacrésFundación Universitaria de Ciencias de la Salud, Bogotá 111411, Colombia.
Carlos Lehmann MosqueraFunctional Unit for Breast and Soft Tissue Tumors, Instituto Nacional de Cancerología, Bogotá 111511, Colombia.
Mauricio García MoraFunctional Unit for Breast and Soft Tissue Tumors, Instituto Nacional de Cancerología, Bogotá 111511, Colombia.
Iván Mariño LozanoFunctional Unit for Breast and Soft Tissue Tumors, Instituto Nacional de Cancerología, Bogotá 111511, Colombia.
Javier Ángel AristizábalFunctional Unit for Breast and Soft Tissue Tumors, Instituto Nacional de Cancerología, Bogotá 111511, Colombia.
Raúl Suarez RodríguezFunctional Unit for Breast and Soft Tissue Tumors, Instituto Nacional de Cancerología, Bogotá 111511, Colombia.
Carlos Alfonso Duarte TorresFunctional Unit for Breast and Soft Tissue Tumors, Instituto Nacional de Cancerología, Bogotá 111511, Colombia.
Ricardo Sánchez PedrazaInstituto Nacional de Cancerología (INC)-Empresa Social del Estado, Universidad Nacional de Colombia, Bogotá 111511, Colombia.ORCID 0000-0002-7540-4734
Instituto Nacional de Cancerología · COFundación Universitaria de Ciencias de la Salud · COUniversidad Nacional de Colombia · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ExtremitiesNeoplasm Recurrence, LocalSarcomaAdultAgedAged, 80 and overColombiaFemaleHumansMaleMiddle AgedPrognosisSoft Tissue Neoplasmsextremitiessarcomasoft tissuestreatment

Identifiers

PMID38668034
PMCPMC11049252
OpenAlexW4393180853

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.